Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,060,500 | 5,888,500 | 4,474,000 | 2,670,100 | 3,695,700 |
| Depreciation Amortization | 457,200 | 680,600 | 650,500 | 1,081,000 | 682,700 |
| Income taxes - deferred | 149,000 | 67,100 | 108,300 | 91,700 | -175,000 |
| Accounts receivable | 2,800 | 68,800 | -205,200 | -435,600 | -241,400 |
| Other Working Capital | -187,200 | 199,300 | 400,200 | 235,400 | 125,200 |
| Other Operating Activity | -252,500 | 174,300 | 759,900 | 908,400 | 500,000 |
| Operating Cash Flow | $4,229,800 | $7,078,600 | $6,187,700 | $4,551,000 | $4,587,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -424,800 | -514,500 | -770,600 | -867,400 | -616,100 |
| Net Acquisitions | -1,006,500 | -120,700 | -1,962,900 | -1,200,000 | -1,200,000 |
| Purchase Of Investment | -6,397,700 | -5,252,600 | -8,371,399 | -5,355,200 | -7,913,200 |
| Sale Of Investment | 7,374,300 | 6,486,300 | 9,173,700 | 5,565,900 | 7,378,900 |
| Purchase Sale Intangibles | -127,000 | -155,000 | -115,500 | -1,095,400 | -111,600 |
| Other Investing Activity | -153,900 | -128,000 | -115,101 | -1,106,400 | -134,400 |
| Investing Cash Flow | $-608,600 | $470,500 | $-2,046,300 | $-2,963,100 | $-2,484,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,967,400 | 0 | 0 | N/A | N/A |
| Debt Repayment | -1,500,000 | N/A | -3,200 | -560,900 | -2,700 |
| Common Stock Issued | -4,600 | 0 | 0 | N/A | -8,500 |
| Common Stock Repurchased | -6,679,100 | -5,868,300 | -4,352,600 | -1,365,400 | -1,000,000 |
| Other Financing Activity | -56,400 | 7,900 | -116,200 | -453,700 | -41,400 |
| Financing Cash Flow | $-5,272,700 | $-5,860,400 | $-4,472,000 | $-2,380,000 | $-1,052,600 |
| Exchange Rate Effect | 69,000 | 400 | -18,600 | 39,400 | -31,300 |
| Beginning Cash Position | 2,913,700 | 1,224,600 | 1,573,800 | 2,326,500 | 1,308,000 |
| End Cash Position | 1,331,200 | 2,913,700 | 1,224,600 | 1,573,800 | 2,326,500 |
| Net Cash Flow | $-1,582,500 | $1,689,100 | $-349,200 | $-752,700 | $1,018,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,229,800 | 7,078,600 | 6,187,700 | 4,551,000 | 4,587,200 |
| Capital Expenditure | -424,800 | -514,500 | -770,600 | -867,400 | -616,100 |
| Free Cash Flow | 3,805,000 | 6,564,100 | 5,417,100 | 3,683,600 | 3,971,100 |